Long-read sequencing to identify unrevealed second hit in autosomal recessive Parkinson’s disease
Objective: Identify unrevealed variants in PRKN and PINK1 genes from young onset Parkinson’s disease (YOPD) patients. Background: Long-read sequencing has identified pathogenic repeats and structural…Assessing Genome-wide Genetic Risk for Parkinson’s Disease in European Sub-Populations Across the Global Parkinson’s Genetics Program and National Biobanks
Objective: To assess genome-wide genetic risk for Parkinson’s disease (PD) within and across genetically determined European ancestries (European, Ashkenazi Jewish, and Finnish) from the Global…Leveraging Large-Scale Proteomics to Identify Protein Quantitative Trait Loci and Causal Effects on Parkinson’s Disease
Objective: Integrate proteomics from the cerebrospinal fluid (CSF) and urine from the Parkinson’s Progression Markers Initiative cohort to prioritize the risk variants associated with Parkinson’s…Young onset Dystonia-Parkinsonism, Intellectual Disability & Mineral deposits in Basal ganglia – Think “RAB39B” mutation
Objective: Please consider RAB39B gene when encountering a young onset dystonia Parkinson phenotype alongside non-progressive intellectual disability and brain mineral deposits. This consideration is crucial…LRRK2 Gene Mutation in Parkinson’s Disease
Objective: We aim to describe the clinical characteristics of PD linked to an LRRK2 mutation. Background: One of the most common monogenic forms of Parkinson's…Spectrum of Movement Disorders in Vitamin B12 Deficiency: A Case Series from India
Objective: We present a case series of movement disorders associated with vitamin B12 deficiency Background: Vitamin B12 deficiency can cause multiple neuropsychiatric disorders like peripheral…PMM2 mutation
Objective: describe glycosylation type 1A PMM2 mutation presented as motor development regression and cognitive impairment proving to be a disease that should’ve been detected precociously.…Deep brain stimulation-evoked potentials as an avenue to optimize stimulation outcomes in Parkinson’s disease
Objective: Use deep brain stimulation (DBS)-evoked potentials recorded using dry-EEG electrodes to estimate stimulation outcome. Background: Subthalamic DBS effectively alleviates motor symptoms in Parkinson’s disease.…Levels of change in interleukin-6 levels according to clinical stages of Parkinson’s disease in patients with and without Covid-19
Objective: Comparison of serum IL-6 levels in clinical stages Parkinson's disease patients with and without Сovid-19. Background: Elevated levels of the cytokine IL-6 may indicate…Analysing the bradykinesia features combination in people with Parkinson’s disease and elderly healthy individuals
Objective: To evaluate, through kinematic analysis, the major phenomenological features of bradykinesia, with a specific focus on their combination, in a relatively large sample of…
- « Previous Page
- 1
- …
- 93
- 94
- 95
- 96
- 97
- …
- 181
- Next Page »